摄入原水解剂后生物活性的吸收:在健康个体中进行的一项随机双盲交叉研究
Nicolina Virgilio1, Christiane Schön2, Yvonne Mödinger2
1Rousselot BV, Ghent, Belgium.
Frontiers in nutrition
|August 16, 2024
概括
来自各种来源和分子量的原化物 (CH) 显示了与氧 (Hyp) 的可比吸收. 这表明,CH有效地提供含有Hyp的,支持它们在功能性食品中的生物可用性.
科学领域:
- 营养生物化学 营养生物化学
- 药理动力学 药理动力学
- 食品科学 食品科学 食品科学
背景情况:
- 原化物 (CH) 是功能性食品和补充剂的关键成分,提供氨基酸 (AAs) 和.
- 人们已经认识到CH具有潜在的健康益处,因此需要进行生物可用性研究.
- 这项研究的重点是来自不同分子重量的鱼,猪和牛来源的皮肤和皮肤衍生CH.
研究的目的:
- 评估一次剂量的原化物生物可用性.
- 为了比较来自不同动物来源 (鱼,猪,牛) 的CH的吸收.
- 评估分子量 (2,000 和 5,000 Da) 对CH生物可用性的影响.
主要方法:
- 一项随机,双盲,交叉临床研究与健康的志愿者进行.
- 测量了自由和与结合的氧素 (Hyp) 的血度.
- 量化了特定的原衍生,以评估吸收.
主要成果:
- 所有测试的原化物都显示出可比的自由氧的吸收.
- 与自由Hyp相比,总Hyp的升高水平表明含有Hyp的二和三的显著吸收.
- CH的来源和分子量并没有阻碍关键代谢物的血度.
结论:
- 来自不同来源和分子重量的原解液被有效吸收.
- 这项研究证实了CH的氧和相关的生物可用性.
- 需要进一步的研究来确定生理效应的最佳代谢物水平.
更多相关视频
08:43Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
7.6K
04:50Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
Published on: August 4, 2023
1.0K
相关概念视频
Protein Digestion
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
Protein Absorption
Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
